AI assistant
DIMERIX LIMITED — Capital/Financing Update 2012
Dec 19, 2012
64804_rns_2012-12-19_0a4b36f7-ccfb-418e-9883-8ac6228e8b90.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [234 x 86] intentionally omitted <==
20 December 2012
The Manager Company Announcements Platform ASX Limited
SBN Rights Issue – Allotment of shortfall shares
Sun Biomedical Limited (ASX: SBN) advises that the shortfall shares in relation to the Company’s non-renounceable rights issue, fully underwritten by CPS Securities[1] , (131,366,830 fully paid, ordinary shares in the Company) were allotted on 20 December 2012. Holding certificates will be despatched shortly.
The total number of shares in the Company on issue following the allotment of the shortfall shares is 331,140,008.
Yours faithfully
==> picture [112 x 19] intentionally omitted <==
==> picture [112 x 19] intentionally omitted <==
Alfonso Grillo Company Secretary
1 Cunningham Peterson Sharbanee Securities Pty Ltd
Sun Biomedical
Limited
Investor Communications
Computershare T: +61 1300 850 505 | F: +61 3 9473 2500
ASX:SBN www.sunbiomed.com
ABN 18 001 285 230